Network-based study reveals potential infection pathways of hepatitis-c leading to various diseases

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Mukhopadhyay, Anirban ^a   Maulik, Ujjwal ^b  

^a UNIVERSITY OF KALYANI   (India)

^b JADAVPUR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ALGORITHM; ARTICLE; COMPUTER NETWORK; DATA MINING; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS HUMAN INTERACTION NETWORK; HUMAN PROTEIN DISEASE ASSOCIATION NETWORK; HUMAN PROTEIN INTERACTION NETWORK; MALIGNANT NEOPLASTIC DISEASE; PATHOGENESIS; PROTEIN TARGETING; QUASI BICLIQUE MINING ALGORITHM; QUASI CLIQUE MINING ALGORITHM; VIRUS CELL INTERACTION; BIOLOGY; GENE ONTOLOGY; HEPACIVIRUS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN DATABASE; PROTEIN PROTEIN INTERACTION;

ALGORITHMS; COMPUTATIONAL BIOLOGY; DATA MINING; DATABASES, PROTEIN; GENE ONTOLOGY; HEPACIVIRUS; HEPATITIS C; HUMANS; PROTEIN INTERACTION MAPS; VIRAL PROTEINS;

EID: 84899724327     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094029     Document Type: Article

References (53)

1. Panchenko A, Przytycka T (2008) Protein-protein Interactions and Networks: Identification, Computer Analysis, and Prediction, volume 9. London: Springer-Verlag.
2. Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, et al. (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proceedings of the National Academy of Sciences, USA 10: 4569-4574. (Pubitemid 32295017)
3. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, et al. (2000) A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403: 623-627. (Pubitemid 30103994)
4. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, et al. (2005) Towards a proteomescale map of the human protein-protein interaction network. Nature 437: 1173-1178. (Pubitemid 41509356)
5. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, et al. (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122: 957-968. (Pubitemid 41345212)
6. Gavin AC, Bsche M, Krause R, Grandi P, Marzioch M, et al. (2002) Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415: 141-147. (Pubitemid 34059510)
7. Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, et al. (2002) Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrom-etry. Nature 415: 180-183. (Pubitemid 34059520)
8. Huang J, Schreiber SL (1997) A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets. Proceedings of the National Academy of Sciences, USA 94: 13396-13401. (Pubitemid 28009592)
9. Arkin MR, Wells JA (2004) Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nature Reviews Drug Discovery 3: 301-317. (Pubitemid 38499758)
10. Tastan O, Qi Y, Carbonell J, Klein-Seetharaman J (2009) Prediction of interactions between HIV-1 and human proteins by information integration. In: Proceedings of the Pacific Symposium on Biocomputing. pp. 516-527.
11. MacPherson JI, Dickerson JE, Pinney JW, Robertson DL (2010) Patterns of HIV-1 Protein Interaction Identify Perturbed Host-Cellular Subsystems. PLoS Comput Biol 6: e1000863+.
12. Mukhopadhyay A, Maulik U, Bandyopadhyay S, Eils R (2010) Mining association rules from hivhuman protein interactions. In: Proc. Intl. Conf. con Systems in Medicine and Biology (ICSMB 2010). pp. 344-348.
13. Maulik U, Bhattacharyya M, Mukhopadhyay A, Bandyopadhyay S (2011) Identifying the immunodeficiency gateway proteins in humans and their involvement in microrna regulation. Mol BioSyst 7: 1842-1851.
14. Mukhopadhyay A, Maulik U, Bandyopadhyay S (2012) A novel biclustering approach to association rule mining for predicting hiv-1-human protein interactions. PLoS ONE 7: e32289.
15. Mukhopadhyay A, Ray S, Maulik U (2014) Incorporating the type and direction information in predicting novel regulatory interactions between hiv-1 and human proteins using a biclustering approach. BMC Bioinformatics 15: 26.
16. Lorenz IC (2010) The hepatitis C virus nonstructural protein 2 (NS2): An up-and-coming antiviral drug target. Viruses 2: 1635-1646.
17. Tripathi LP, Kataoka C, Taguwa S, Moriishi K, Mori Y, et al. (2010) Network based analysis of hepatitis C virus Core and NS4B protein interactions. Mol BioSyst 6: 2539-2553.
18. Popescu CI, Callens N, Trinel D, Roingeard P, Moradpour D, et al. (2011) NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly. PLoS Pathog 7: e1001278.
19. Zheng S, Tansey WP, Hiebert SW, Zhao Z (2011) Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma. BMC Med Genomics 4: 62.
20. Kwofie SK, Schaefer U, Sundararajan VS, Bajic VB, Christoffels A (2011) HCVpro: Hepatitis C virus protein interaction database. Infect Genet Evol.
21. Bhattacharyya M, Bandyopadhyay S (2009) Solving maximum fuzzy clique problem with neural networks and its applications. Memetic Computing 1: 281-290.
22. Bhattacharyya M, Bandyopadhyay S (2012) Bounds on Quasi-Completeness, LNCS, Springer. IWOCA.
23. Jain AK, Dubes RC (1988) Algorithms for Clustering Data. Englewood Cliffs, NJ: Prentice-Hall.
24. Mukhopadhyay A, Maulik U, Bandyopadhyay S (2007) Multiobjective genetic fuzzy clustering of categorical attributes. In: Proc. 10th International Conference on Information Technology (ICIT 2007). pp. 74-79.
25. Mukhopadhyay A, Maulik U, Bandyopadhyay S (2010) On biclustering of gene expression data. Current Bioinformatics 5: 204-216.
26. de Chassey B, Navratil V, Tafforeau L, Hiet MS, Aublin-Gex A, et al. (2008) Hepatitis C virus infection protein network. Mol Syst Biol 4: 230.
27. Zhang Y, De S, Garner JR, Smith K, Wang SA, et al. (2010) Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information. BMC Medical Genomics 21.
28. Osna NA, White RL, Krutik VM, Wang T, Weinman SA, et al. (2008) Proteasome activation by hepatitis C core protein is reversed by ethanol-induced oxidative stress. Gastroenterology 134: 2144-2152. (Pubitemid 351783253)
29. Suzuki R, Moriishi K, Fukuda K, Shirakura M, Ishii K, et al. (2009) Proteasomal turnover of hepatitis C virus core protein is regulated by two distinct mechanisms: a ubiquitin-dependent mechanism and a ubiquitin-independent but PA28gamma-dependent mechanism. Journal of Virology 83: 2389-2392.
30. Klco JM, Geng B, Brunt EM, Hassan A, Nguyen TD, et al. (2010) Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility. American Journal of Hematology 85: 106-110.
31. Zhang L, Jilg N, Shao RX, Lin W, Fusco DN, et al. (2011) IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway. Journal of Hepatology 55: 289-298.
32. Welbourn S, Jirasko V, Breton V, Reiss S, Penin F, et al. (2009) Investigation of a role for lysine residues in non-structural proteins 2 and 2/3 of the hepatitis C virus for their degradation and virus assembly. Journal of General Virology 90: 1071-1080.
33. Negro F (2009) Peroxisome Proliferator-Activated Receptors and Hepatitis C virus-induced insulin resistance. PRAR Research.
34. Kim BK, Choi YS, Park YH, Lee SU (2011) Interferon-alpha-induced destructive thyroiditis followed by Graves' disease in a patient with chronic hepatitis C: a case report. J Korean Med Sci 26: 1638-1641.
35. Chen LK, Chou YC, Tsai ST, Hwang SJ, Lee SD (2005) Hepatitis C virus infection-related Type 1 diabetes mellitus. Diabet Med 22: 340-343.
36. Giordanino C, Ceretto S, Bo S, Smedile A, Ciancio A, et al. (2012) Type 2 diabetes mellitus and chronic hepatitis C: which is worse? Results of a long-term retrospective cohort study. Dig Liver Dis 44: 406-412.
37. Tsuge M, Fujimoto Y, Hiraga N, Zhang Y, Ohnishi M, et al. (2011) Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse. PLoS ONE 6: e23856.
38. Yamamoto T, Katayama I, Nishioka K (1995) Psoriasis and hepatitis C virus. Acta Derm Venereol 75: 482-483. (Pubitemid 26051892)
39. Ouwe-Missi-Oukem-Boyer O, Ndouo FS, Ollomo B, Mezui-Me-Ndong J, Noulin F, et al. (2011) Hepatitis C virus infection may lead to slower emergence of P. falciparum in blood. PLoS ONE 6: e16034.
40. Salcedo-Mora X, Mate J, Medina J, Nam Cha SJ, Gisbert JP, et al. (2006) Chronic hepatitis C and Crohn's disease: nosocomial infection treatment with PEG-interferon plus ribavirin. Digestion 73: 210-214. (Pubitemid 44448881)
41. Hou JK, Velayos F, Terrault N, Mahadevan U (2010) Viral hepatitis and inflammatory bowel disease. Inflamm Bowel Dis 16: 925-932.
42. Perlemuter G, Cacoub P, Sbai A, Hausfater P, Thibault V, et al. (2003) Hepatitis C virus infection in systemic lupus erythematosus: a case-control study. J Rheumatol 30: 1473-1478. (Pubitemid 36835441)
43. Ferri C, Sebastiani M, Antonelli A, Colaci M, Manfredi A, et al. (2012) Current treatment of hepatitis C-associated rheumatic diseases. Arthritis Res Ther 14: 215.
44. de Oliveria Andrade LJ, D'Oliveira A, Melo RC, De Souza EC, Costa Silva CA, et al. (2009) Association between hepatitis C and hepatocellular carcinoma. J Glob Infect Dis 1: 33-37.
45. Su FH, Chang SN, Chen PC, Sung FC, Su CT, et al. (2011) Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study. BMC Cancer 11: 495.
46. Emilia G, Luppi M, Ferrari MG, Barozzi P, Marasca R, et al. (1997) Hepatitis C virus-induced leuko-thrombocytopenia and haemolysis. J Med Virol 53: 182-184. (Pubitemid 27445738)
47. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638. (Pubitemid 36459468)
48. Mohamed AA, Loutfy SA, Craik JD, Hashem AG, Siam I (2011) Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma. Virol J 8: 496.
49. Omland LH, Farkas DK, Jepsen P, Obel N, Pedersen L (2010) Hepatitis C virus infection and risk of cancer: a population-based cohort study. Clin Epidemiol 2: 179-186.
50. Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, et al. (2005) Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol 11: 1843-1847. (Pubitemid 40520782)
51. Nanda KS, Ryan EJ, Murray BF, Brady JJ, McKenna MJ, et al. (2009) Effect of chronic hepatitis C virus infection on bone disease in postmenopausal women. Clin Gastroenterol Hepatol 7: 894-899.
52. Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, et al. (2009) Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis 49: 225-232.
53. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, et al. (2009) Risk of hepatobiliary and pancreatic cancers after hepatitis c virus infection: A population-based study of u.s. veterans. Hepatology 49: 116-123.